SY

Saurabh Yadav

Active Director Director DIN 08964316
DIN 08964316 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Saurabh Yadav

Data last updated:

Saurabh Yadav is a Director at Relward Pharma Private Limited (since 2020). The company operates in Pharma. Relward Pharma Private Limited reported revenue of ₹3.37 Cr (FY 2024).

DIN 08964316
Primary Designation Director
Industry Pharma
First Appointment 18 Nov 2020
Oldest Company Age 5 yrs
Largest company Relward Pharma Private Limited · ₹3.37 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Relward Pharma Private Limited U24299HR2020PTC090989
Director18 Nov 20202020₹3.37 Cr (FY 2024)Active

Board colleagues of Saurabh Yadav

NameDINCompanyDesignation
Krishak Malik08200648Relward Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Relward Pharma Private Limited
Premium access

Shareholding and investment profile for Saurabh Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh Yadav

Saurabh Yadav currently holds 1 directorship: Relward Pharma Private Limited (Director, since 18 Nov 2020, revenue ₹3.37 Cr (FY 2024)).

Saurabh Yadav was first appointed on 18 Nov 2020 as Director at Relward Pharma Private Limited.

The current boards of Saurabh Yadav's companies include Krishak Malik (Relward Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available